Payal Shah

Payal Shah is a CME Group’s Director of Equity Research and Product Development. She was responsible for leading the research and development of new and innovative products in the equity and alternative investment markets. Since joining the company in 2016, Shah has been involved in the crypto space and the creation of Cryptocurrency Reference Rates, Bitcoin Futures and Options Contracts, and Ether Futures. 

Shah also serves on the CME CF Cryptocurrencies Oversight Committee. Before joining CME Group, Shah was an ETF Specialist at MSCI and held trading roles within the Equity Derivatives Group at Morgan Stanley.